St. Luke's John Spertus demonstrates the RESOLVE stroke tool

127 views · Published 18 March 2016 · 3:01 · Indexed 10 November 2026

Channel: Kansas City Star · 2016 · News & Politics

Watch on YouTube

Tissue plasminogen activator, or tPA, can minimize disability in a patient following a stroke, but the drug can also cause catastrophic bleeding in the brain.  A national team of researchers, led by cardiologist John Spertus at St. Luke’s Hospital, is hoping to give physicians more confidence with tPA.  Spertus, clinical director of Cardiovascular Outcomes Research, demonstrates the RESOLVE tool that can instantly calculate the risks and benefits of tPA for individual stroke patients based on a few simple factors.  By Jill Toyoshib

More from this channel